Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology

Hong Kong Liver Cancer (HKLC) staging system was developed for prognostic and treatment evaluation for hepatocellular carcinoma (HCC) but is not externally validated. We aimed to evaluate and compare HKLC system with Barcelona Clínic Liver Cancer (BCLC) staging system. The prognostic performance, di...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Su, Chien-Wei, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616786/
https://www.ncbi.nlm.nih.gov/pubmed/26469917
http://dx.doi.org/10.1097/MD.0000000000001772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616786/
https://www.ncbi.nlm.nih.gov/pubmed/26469917
http://dx.doi.org/10.1097/MD.0000000000001772

Ejemplares similares